Latest Asx Listing Rules News

Avecho Biotechnology has responded to an ASX price query, confirming no undisclosed information exists to explain recent trading spikes, while highlighting market speculation linked to its Phase III CBD insomnia trial.

Laramide Resources Ltd. has acknowledged a delayed filing of a director's interest notice due to internal illness, prompting an ASX inquiry and procedural upgrades to prevent future lapses.

Pure Foods Tasmania Limited (ASX: PFT) will recommence trading on the ASX from 14 February 2025 following the lifting of its suspension after submitting reissued financial statements with an unqualified audit opinion.

Pure Foods Tasmania has executed key loan extensions with Commonwealth Bank and outlined a comprehensive turnaround strategy to address its financial challenges, despite ongoing material uncertainty over its going concern status.

Pioneer Lithium has successfully raised $1.3 million in the first tranche of a $1.62 million placement, earmarked to accelerate its uranium project development. A second tranche awaits shareholder approval, signaling continued momentum for the company’s strategic growth.

Adelong Gold Limited has secured an additional $400,000 through a placement, increasing total funds raised to $1.573 million. This capital injection aims to fast-track exploration and development at its flagship gold project and lithium assets in Brazil.

Caprice Resources responds to ASX price query by releasing validated exploration results from its Island Gold Project, following a trading halt triggered by unusual market activity.

Titanium Sands Limited has raised $500,000 through a placement to advance environmental approvals and mining licence progress for its Mannar Island Heavy Mineral Project in Sri Lanka.

New Zealand Coastal Seafoods Limited has raised $18,000 through a convertible note subscription, reinforcing its financial position and enabling accelerated strategic initiatives focused on sustainable seafood.

Vitura Health has raised $5.1 million from prominent investor Professor Khalil Shahin, marking a significant step towards acquiring Candor Medical and accelerating its digital health expansion.

BMG Resources has addressed ASX's query on recent share price and volume spikes, confirming no undisclosed information but highlighting imminent assay results from its Abercromby Gold Project.

Sarama Resources has completed the second tranche of its A$2 million equity placement, issuing options to institutional investors after shareholder approval. The funds are earmarked for advancing exploration and supporting working capital.